CommercialCoverageMedium impact
06.02.44s, Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments
Independence Blue Cross·Pain Management, Psychiatry, Family Medicine +1 more·Pharmacy
Effective date
Jun 5, 2026
We identified it
Jun 19, 2026
Summary
Policy 06.02.44s addresses drug testing procedures for substance abuse and pain management treatments, involving changes to coverage positions, medical necessity criteria, and medical coding guidelines. This affects billing and reimbursement for presumptive and definitive drug testing services.
Action Required
Before June 5, 2026: Billing team must review updated policy 06.02.44s for drug testing in substance abuse and pain management. Update billing procedures for presumptive and definitive drug testing based on new medical necessity criteria and coding guidelines. Providers should ensure documentation meets revised requirements to avoid claim denials.